Cerevel Competitors and Similar CompaniesClear all
Cerevel's competitors and similar companies include Alexion Pharmaceuticals, AM Pharma, MediWound and UNITY Biotechnology.
 Cerevel Cerevel Therapeutics Holdings is a biopharmaceutical company focused on developing therapies to treat disorders of the central nervous system (CNS). |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. | |||
Founding Date | Founding Date 2018 | Founding Date 1992 | Founding Date 2001 | Founding Date 2001 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ Cambridge, US | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations Utrecht, NL HQ Utrecht, NL | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations South San Francisco, US HQ |
Employees | Employees 598% decrease | Employees 10,6006% increase | Employees 28 | Employees 111 | Employees 98 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 40.3 b | Valuation ($) N/A | Valuation ($) 196.3 m | Valuation ($) 23.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $17m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $553.5m (FY, 2020) | Cost of goods N/A | Cost of goods $13.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $5.5b (FY, 2020) | Gross profit N/A | Gross profit $4.1m (FY, 2025) | Gross profit N/A |
Net income | Net income ($432.8m) (FY, 2023) | Net income $603.4m (FY, 2020) | Net income N/A | Net income ($23.9m) (FY, 2025) | Net income ($26m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 350m | Total funding raised N/A | Total funding raised $ 210.3m | Total funding raised N/A | Total funding raised $ 210.6m |
For sources of this data, please see the company profile
View Company Profiles
Alexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View company
AM Pharma
HQ
Utrecht, NL
Employees
28
AM-Pharma is a biopharmaceutical company that develops medicines for patients.
View companyMediWound
HQ
Yavne, IL
Employees
111
MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.
View company
UNITY Biotechnology
HQ
South San Francisco, US
Employees
98
Unity Biotechnology designs therapeutics that prevent various diseases of aging.
View company